Summit Therapeutics股票討論區

$Summit Therapeutics(SMMT.US)$
i think this stock may be ready to crash. still no income, the whole company betting on the approval of ivonescinab, riiisky

$Summit Therapeutics(SMMT.US)$ Ankur Dhingra, Chief Financial Officer, on March 26, 2024, executed a purchase for 100,000 shares in Summit Therapeutics (SMMT) for $375,000. Following the Form 4 filing with the SEC, Dhingra has control over a total of 354,958 shares of the company, with 354,958 shares controlled indirectly.

$Summit Therapeutics(SMMT.US)$ Summit Therapeutics Announced Data For Ivonescimab In Advanced Non-small Cell Lung Cancer, That Is Being Presented At The 2024 European Lung Cancer Congress
Benzinga· 3 mins ago
Ivonescimab alone or combined with chemotherapy led to intracranial responses among 34% of patients with brain metastases at baseline – 23% achieved a complete response
All patients who did not achieve an intracranial response demonstrated stable disease or non-progression by RANO cri...

$Summit Therapeutics(SMMT.US)$ anyone heard any news on SMMT? the stock is taking off

$Summit Therapeutics(SMMT.US)$ Officer Dhingra Ankur purchased 20,400 shares of Common Stocks on Dec 13, 2023 at an average price of $2.17 for a total value of $44,254.
Officer Zanganeh Mahkam purchased 5,000 shares of Common Stocks on Dec 12, 2023 at an average price of $2.07 for a total value of $10,350.

$Summit Therapeutics(SMMT.US)$ alerted 1.8
$阿莎娜(ASAN.US)$ alerted 17